麻醉学（英文版）.pdf

THISMONTHINAnesthesiologyPhaseIIStudytoEvaluatetheSafetyandEfficacyofIncidenceofEpiduralCatheter-theOralNeurokinin-1ReceptorAntagonistCasopitantassociatedInfectionsafterContinuousEpiduralAnalgesiain(GW679769)AdministeredwithOndansetronfortheChildren(ReviewArticle)224PreventionofPostoperativeandPostdischargeNauseaandVomitinginHigh-(PONV)usinganoraldoseoftheneurokinin-1receptorantagonistcasopi-tantandanintravenousdoseofondansetronhy-AssociationbetweenEpiduraldrochlorideinpremenopausalorperimeno-AnalgesiaandCancerpausaladultwomen(Nϭ702)withahistoryofRecurrenceafterColorectalPONVand/ormotionsicknessundergoingaCancerSurgery27laparoscopic/-4mgwithorwithoutcasopitant(0mg,50mg,,or150mg)-pleteresponse(novomiting,retching,rescuemedication,orprematurewithdrawalduringtheRelationshipbetweenAnestheticfirst24hafteranesthesia)versusondansetronalone(59–62%%,respectively).binationtherapywithcasopitantandondansetronprotectedagainstPONVinthe24--(Double-bonded)poundsGantacurium(AV430A),CW002,andCW01158Gantacuriumisanultra-short-actingneuromuscularblockerthatisrapidlychemicallydegradedinvitroviaSupernatantofAgedL-cysteineadductionandpreliminarydatasuggestthatexogenousintravenousL-cysteineabolishesganta--cysteineadductioninvitro(t1⁄2)paredwithina“Two-Hit”InVivoSyngeneicgantacurium(CW002,;CW011,